HeyJaredThe AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases
AD/PD™ is the leading international platform dedicated to exploring the latest breakthroughs and treatments in Alzheimer's, Parkinson’s, and related neurodegenerative diseases.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Aug 18, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 9, 2026
Latest episodes
pTau217: Clinical and Economic Benefits to the Healthcare System (opens the original)
Read excerpt
In this episode, Dr. Soeren Mattke, physician and health services researcher at the University of Southern California, explores the growing role of blood-based biomarkers in the diagnosis and evaluation of Alzheimer’s disease. He discusses how blood tests could make Alzheimer’s diagnosis faster, more accurate, and more scalable, helping to reduce pressure on specialist services and integrate diagnosis more effectively into primary care. The episode also examines their potential applications beyo
Neuropathology in the Biomarker Age & Sleep in Lewy Body Disease, AD/PD™ Session Spotlight (opens the original)
Read excerpt
In this episode, we spotlight Plenary Lectures 01 and 02 from the AD/PD™ 2026 International Conference , held on March 17, 2026. The lectures were chaired by Sandra O. Moose (USA) and Prof. Gabriel Gold (Switzerland). Plenary Lecture 01, "Understanding Neurodegenerative Diseases Today: Lessons from Clinicopathological Correlations and the Ongoing Role of Neuropathology in the Biomarker Age," was presented by Prof. Lea Grinberg (USA). Plenary Lecture 02, the Eric N. Birch Lecture, "Key Sleep Issu
Moonshots and Milestones: Is the Future of Neurodegeneration Drug Discovery in Startups, Big Pharma, or Academia? AD/PD™ Session Spotlight (opens the original)
Read excerpt
In this episode, we will cover the Fireside Debate "Moonshots and Milestones: Is the Future of Neurodegeneration Drug Discovery in Startups, Big Pharma, or Academia?" that took place on March 17, 2026 at the AD/PD™ 2026 International Conference . The debate was moderated by Dr. Henrietta Nielsen (Sweden) and Prof. Philip Scheltens (Netherlands), with expert contributions from Dr. Geoffrey Kerchner (Switzerland), Prof. Cynthia Lemere (USA), Dr. Mark Mintun (USA), Dr. Marco Prado (Canada), and Pro
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases